GoodRx's Thomas Chan converts awards to 5,793 shares
The same-day report includes 2,948 shares delivered or withheld for payment of exercise price or tax liability at a reported $3.38 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
GoodRx Holdings, Inc. Chief Accounting Officer Thomas (TC) Chan reported converting 5,793 restricted stock units into 5,793 shares of Class A common stock on October 15, 2026. The reported derivative holdings following the transaction were 52,132 restricted stock units. On the same date, 2,948 shares were delivered or withheld for payment of exercise price or tax liability, with a reported per-share price of $3.38.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit F1, F2 | 5,793 | $0.00 | $0.00 |
| Exercise | Class A Common Stock F1 | 5,793 | -- | -- |
| Exercise Price or Tax Liability | Class A Common Stock | 2,948 | $3.38 | $10K |
Footnotes (2)
- F1. Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
- F2. This restricted stock units award vests with respect to 1/12 of the award in quarterly installments on April 15, 2026 and on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each applicable vesting date.
Key Figures
Key Terms
restricted stock unit financial
vests financial
tax liability financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What were the vesting terms for Thomas Chan's GDRX RSUs?
AI-generated analysis. How Rhea-AI works. Not financial advice.